| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Casting Off The Chains: Drive Up Productivity Through Team Mobility |
|
E-Folder - Casting Off The Chains: Drive Up Productivity Through Team Mobility
For most sales focused organisations – any employee ‘down time’ is dead time and constitutes a direct impact on the profit margin. Many companies are chasing the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Elysian dream of reducing this loss and therefore driving up margins through the implementation of ‘remote access technologies’, but they may well be missing th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in point entirely… In reality, the provision of ‘gadgets’ to field operatives without a unified ‘team’ communication model will not improve, but in fact actually lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. reduce focus and lead to a decrease in staff efficiency. Let me put it another way: give your employees more to play with, without enabling real benefits in term here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of ‘team mobility’ and frankly you are wasting your money. There are a variety of elements which should be considered when implementing a deployment strategy o d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro this kind, and yes – you do need a strategy for this to be effective. 1. Provide effective communication between remote operatives, ideally through voice, data ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc and messaging. Do not be lulled into thinking that what is needed is an ‘office desktop’ on the mobile device. Remote field operatives need much more support th easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n their office bound counterparts (see this article http://EzineArticles.com/?id=245765
for gui nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ance on implementation strategy) 2. Implement a means by which the co-ordination of the team and the status of progress on assigned projects/tasks/activities ca and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ be easily evaluated by line management. Make sure remote staff are ‘on task’ by maintaining a dialogue with them in the field and actively offering support to t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi em by whatever means are available. 3. Make your remote staff part of your joined-up corporate business information strategy. All workers – regardless of locat ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ion, should be provided all the information they require in order to maximise productivity. Office located facilities should include drop-in hot-desking and com dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ortable meeting room facilities. These are vitally important as you staff will remain as ever pack animals by nature and group thinking/working and socialising s cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ould be actively encouraged. Home office facilities should fully enable staff to use corporate resources in a secure environment. It is key that steps are taken tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen to avoid an imferred devaluing within the organisation of the contribution made by remote, home office based staff. Remote access technology deployments should t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nclude access to corporate information as above, but also include ‘team centric’ information sharing and project management controls. The advent of full cross-pl ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust tform mobility solutions (such as mobile java based solutions) and collaborative web based virtual team workspaces (such as sharepoint) now allow the same level y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products f cross team information collaboration between field and home workers as previously enjoyed by office based staff. In summary, in order to gain maximum benefit . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rom your remote field and home based workers.. your organisation needs to support them properly – through the use of both team based management techniques and c elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip llaborative technology solutions. Failure to do this will lead to a failure to exploit this extremely cost effective, productive and efficient corporate strategy tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Designers Help Market Commercial Real Estate Business Intelligence - For Proper Decision-Making Tips to Make the Most of Your Media Relations Efforts
|